相关实验视频

Updated: May 27, 2025

Site Specific Lysine Acetylation of Histones for Nucleosome Reconstitution using Genetic Code Expansion in Escherichia coli

Site Specific Lysine Acetylation of Histones for Nucleosome Reconstitution using Genetic Code Expansion in Escherichia coli

Published on: December 26, 2020

炭酸直接向刺C端尾部,以改善刺介导的炎症性疾病

Wenqing Mu^1,2,3, Guang Xu², Ling Li⁴

¹Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

|February 18, 2025

概括

来自迷香的肉酸抑制cGAS-STING通路,这是先天免疫和自身免疫疾病的关键参与者. 这种化合物通过准STING C-终端尾部提供了潜在的治疗策略.

科学领域:

免疫学免疫学免疫学
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

干扰素基因 (STING) 信号通路的循环GMP-AMP合成酶 (cGAS) 刺激器对于先天免疫非常重要.
对cGAS-STING通路的调节失调与各种自身炎症和自身免疫性疾病有关.
需要特定的抑制剂来有效调节这种途径.

研究的目的:

为了研究酸 (CA) 对cGAS-STING信号通路的抑制作用.
阐明CA抑制cGAS-STING激活的机制.
评估CA在炎症和自身免疫疾病模型中的治疗潜力.

主要方法:

生物化学测试以评估CA与STING的直接结合.
分析STING信号的复合体形成和下游信号事件 (例如,TBK1招募,STING/IRF3酸化).
使用自身炎症性疾病模型 (Trex1缺乏) 的体内研究来评估CA的疗效.

主要成果:

肉酸直接与STING C-终端尾部 (CTT) 结合,抑制cGAS-STING通路的激活.
CA 阻止了 TANK 结合激酶 1 (TBK1) 的招募,STING 酸化和 IRF3 核转移.
在Trex1缺乏的自身炎症性疾病模型中,CA显著降低了体内STING介导的炎症,并改善了症状.

结论:

肉酸是cGAS-STING通路的特定抑制剂,通过直接与STING CTT结合而起作用.
酸的基基对其STING抑制活性至关重要.
CA证明了治疗由cGAS-STING信号驱动的炎症和自身免疫疾病的治疗潜力,突出了STING CTT作为药物开发目标.

关键词:

刺激抑制剂刺激抑制剂在Trex1缺乏症下,cGAS-STING 的使用情况.卡尔诺斯酸是什么卡尔诺斯酸炎症反应可能是炎症反应.

更多相关视频

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins

Published on: October 4, 2017

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

相关概念视频

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...